Navigation Links
FDA Panel Finds OTC Cold Remedies Effective
Date:12/14/2007

ylephrine suggested that pill and syrup versions of these medicines offered users no real relief. The researchers had petitioned the FDA to investigate the matter and also examine the possibility of requiring higher doses that would work.

Drug companies have recently turned to phenylephrine as a replacement for another decongestant, pseudoephedrine, to comply with a 2006 U.S. law requiring that products containing pseudoephedrine be sold from behind the counter. The law was designed to prevent these medications from being bought in bulk and turned into methamphetamine.

On the academics' side, according to the AP, was drug maker Schering-Plough, which had decided not to reformulate its Claritin line of decongestants, which contain pseudoephedrine.

"If you have a stuffy nose, and you take an over-the-counter product containing phenylephrine, you will still not be able to breathe through your nose after you take it. That's the bottom line," Leslie Hendeles, a professor of pharmacy and pediatrics at the University of Florida, contended before the advisers met.

Hendeles had led the review, which was published in the July 2006 issue of the Journal of Allergy and Clinical Immunology, and he had petitioned the FDA to boost the maximum allowable dose of phenylephrine in oral decongestants to 25 milligrams, which he believes may be more effective.

"There needs to be a dose-response study where you look a 10-, 25- and 50-milligram doses and determine what dose would give you a relief of your stuffy nose without side effects," he said.

But one expert worried that boosting doses of phenylephrine might come at a price.

"No medicine ever has been shown beyond the shadow of a doubt to be effective for the common cold," noted Dr. Bruce Barrett, an associate professor of family medicine at the University of Wisconsin in Madison. "The main problem with decongestants is that they stimulate the heart a
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Virginia Tech Review Panel Calls For Reform of Mental Health Treatment Law
2. CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation
3. Patient Safety Authority Board of Directors Names Infection Advisory Panel
4. Partners Rx Chief Pharmacy Officer, Richard Bullard on Panel Discussion at the Fall 2007 Managed Markets Summit (MMS) in Phoenix, AZ.
5. Billians HealthDATA GM Speaking on Dreamforce 07 Panel
6. FDA Panel Recommends Approval of SyntheMeds REPEL-CV(R) Adhesion Barrier for Pediatric Patients
7. Abaxis Announces New Waived Kidney Check Panel Exclusively for Imaging and Radiology Centers
8. Health Courts Critic to be Featured Speaker at Wyoming Patient Safety Panel
9. FDA Panel Mulls Ban on Kids Cold Medicines
10. FDA Panel Weighs Ban on Kids Cold Medicines
11. FDA Panel Recommends Ban on Cold Medicines for Kids

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Panel Finds OTC Cold Remedies Effective
FDA Panel Finds OTC Cold Remedies Effective
(Date:11/22/2009)...ause donated cells to attack recipient,s tissue, s...Day News) -- Researchers are reporting that a gene... that someone who,s had a bone-marrow transplant w...t disease. , The immune system-related complic...the variation and the donor does not. , When t...
(Date:11/22/2009)...NGTON, Nov. 21 Congress...ment upon the United States Senate,s vote tonight ...islation: ,, "Senators Arlen Specter and Bob Ca...ennsylvanians for casting stand-up, critical votes... historic Affordable Health Care Reform legislatio...
(Date:11/21/2009)...SHINGTON, Nov. 21 A reg...e onchocerciasis (river blindness) in the Americas...isease in recent years, as evidenced by a 31% decr...rug administration in six endemic countries. Resu... of the American Society of Tropical Medicine and ...
(Date:11/21/2009)... HAPPYneuron,s most popular and addictiv... and iPod Touch. , Mounta...on,s most popular and addictive game, SplitWords, ...it Words is designed to help banish that ,tip of t...iPhone brain game challenges the brain by encoura...
(Date:11/20/2009)...NCETON, NJ, Nov. 20 /PRNewswire-FirstCall/ - NUCRY...ecial Meeting of Shareholders will be held on Mond...is to consider approval of two special resolutions...uthorize the sale of all or substantially all of t...rovided for in the asset purchase agreement dated ...
Breaking Medicine News(10 mins):Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3
...2 Perot Systems,Corporation (NYSE: PER ) and Sur...eement in which Perot Systems will implement advan...r business growth. Through this,agreement, Perot S...ountry. Perot Systems, services will include:,stra...
...a Motor Co., Ltd. will showcase an,experimental mo... walking,for the elderly and other people with wea... on Barrier Free Equipments & Rehabilitation for,t...w.newscom.com/cgi-bin/prnh/20080422/LATU095A ), D...
... 2008 Help is on the way for patients who have un...om chronic pain in their backs and legs, thanks to...pain management specialists. , Called a hybrid ...pheral nerve field stimulation (PNFS). This lates...
...ity, may abolish post-operative arthritic knee pai...ective surgery to repair a common sports-related k...nt), is now available in Michigan., "This innovat...o a degree never seen before with traditional ACL,...
...ints to a new strategy for preventing or possibly ...organ and tissue damage researchers at the Unive...have determined that a molecule called Epac (Excha...ine edition of the Proceedings of the National Aca...
...OrbusNeich,s Genous Bio-engineered,R stent will be...sty Summit,TCT 2008 Asia Pacific., The symposium,...on,Center of Sheraton Grande Walkerhill Seoul Hote...al Progenitor Cell Capture Technology and Beyond" ...
Other Medicine News:Health News:Perot Systems and Surgical Care Affiliates Sign Five-Year Agreement to Implement Advanced Technology Solutions 2Health News:Perot Systems and Surgical Care Affiliates Sign Five-Year Agreement to Implement Advanced Technology Solutions 3Health News:Honda to Showcase Experimental Walking Assist Device 2Health News:Mix of 2 pain-relief procedures can end chronic back and leg pain without drugs 2Health News:Mix of 2 pain-relief procedures can end chronic back and leg pain without drugs 3Health News:Two Michigan Orthopedic Surgeons Pioneer Innovative ACL Surgery with New Benefits for Athletes, Weekend Warriors 2Health News:Two Michigan Orthopedic Surgeons Pioneer Innovative ACL Surgery with New Benefits for Athletes, Weekend Warriors 3Health News:Scientists identify novel way to prevent cardiac fibrosis 2Health News:Symposium at Angioplasty Summit TCT Asia Pacific 2008 Features OrbusNeich's Genous(TM) Bio-engineered R stent(TM) 2
(Date:11/20/2009)... , PLYMOUTH MEETING, Pa., Nov. 20 /PRNewswir... Times article that questions why currently avail...e cancers are being ignored, ECRI Institute, an in...admap to the evidence on Finasteride for Preventi...The November 13, 2009, New York Times article, "...
(Date:11/20/2009)..., MEMPHIS, Tenn., Nov. 20 /PRNewswire-FirstCa...dics Division is pleased to announce the signing o...d States Department of Defense that may lead to th...to revolutionize the treatment of the limbs of sol... year, the Defense Advanced Research Projects Agen...
(Date:11/19/2009)... , ARDEE, Ireland, Nov. 19 War...the pricing of its previously announced secondary ... price to the public of $22.25 per share. The sel...in Capital Partners, DLJ Merchant Banking, J.P. Mo... H. Lee Partners, L.P., certain other institutiona...
Breaking Medicine Technology:ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4CEM Wins Presidential Green Chemistry Challenge Award for the Sprint Rapid Protein Analyzer 12724 1CEM Wins Presidential Green Chemistry Challenge Award for the Sprint Rapid Protein Analyzer 12724 2KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10 K 49600 1KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10 K 49600 2KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10 K 49600 3KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10 K 49600 4KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10 K 49600 5KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10 K 49600 6 New Strategy Eyed for AIDS Treatment 49598 1 New Strategy Eyed for AIDS Treatment 49598 2
...itor, and R7128, nucleoside polymerase inhibitor, ...n patients with hepatitis C - , , NUTLEY, N.J., ...oche, InterMune, Inc. (Nasdaq: ITMN ) and Pharma...esults from their innovative, interferon-free regi...herapy for the treatment of patients chronically i...
...rmed to date will be presented during the Internat...nnual Meeting in Paris, France on April 24, 2009 ...d as an in vitro assessment of cell-mediated imm...erous clinical investigations have contributed to ...g recipients of solid organ transplants. , , (Lo...
Other Medicine Technology:Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 2Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 3Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 4Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 5Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 6Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 7Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 8Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 9Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 10Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 11An Independent Study Reports on the Utility of ImmuKnow(R), the Cylex(TM) Immune Cell Function Assay, for Monitoring Heart Transplant Recipients 2
...cientific principles supporting the effectiveness ...sed upon extensive clinical studies. As a woman ne...vel increases, thereby, elevating the salt in her ...ed to dry, crystalization occurs. The closer a wom...
Gastroccult Gastric Occult and pH Test
SureStep™ FSH Menopause Test (mid-stream)
FSH Home Menopause Test Midstream (Urine)
Medicine Products: